184 related articles for article (PubMed ID: 30505056)
1. Comparative effect of manuka honey on anaerobic parasitic protozoans with standard drug therapy under
Sinha S; Prakash A; Sehgal R; Medhi B
Indian J Pharmacol; 2018; 50(4):197-203. PubMed ID: 30505056
[TBL] [Abstract][Full Text] [Related]
2. In vitro effect of nitazoxanide against Entamoeba histolytica, Giardia intestinalis and Trichomonas vaginalis trophozoites.
Cedillo-Rivera R; Chávez B; González-Robles A; Tapia A; Yépez-Mulia L
J Eukaryot Microbiol; 2002; 49(3):201-8. PubMed ID: 12120985
[TBL] [Abstract][Full Text] [Related]
3. Metronidazole and Secnidazole Carbamates: Synthesis, Antiprotozoal Activity, and Molecular Dynamics Studies.
Rocha-Garduño G; Hernández-Martínez NA; Colín-Lozano B; Estrada-Soto S; Hernández-Núñez E; Prieto-Martínez FD; Medina-Franco JL; Chale-Dzul JB; Moo-Puc R; Navarrete-Vázquez G
Molecules; 2020 Feb; 25(4):. PubMed ID: 32059495
[TBL] [Abstract][Full Text] [Related]
4. Highly Potent 1
Kumar S; Bains T; Won Kim AS; Tam C; Kim J; Cheng LW; Land KM; Debnath A; Kumar V
Front Cell Infect Microbiol; 2018; 8():380. PubMed ID: 30425970
[TBL] [Abstract][Full Text] [Related]
5. Synthesis and antiprotozoal activity of some 2-(trifluoromethyl)-1H-benzimidazole bioisosteres.
Navarrete-Vázquez G; Rojano-Vilchis Mde M; Yépez-Mulia L; Meléndez V; Gerena L; Hernández-Campos A; Castillo R; Hernández-Luis F
Eur J Med Chem; 2006 Jan; 41(1):135-41. PubMed ID: 16260067
[TBL] [Abstract][Full Text] [Related]
6. 5-Nitroimidazole drugs effective against metronidazole-resistant Trichomonas vaginalis and Giardia duodenalis.
Upcroft JA; Dunn LA; Wright JM; Benakli K; Upcroft P; Vanelle P
Antimicrob Agents Chemother; 2006 Jan; 50(1):344-7. PubMed ID: 16377707
[TBL] [Abstract][Full Text] [Related]
7. In vitro effect of tinidazole and furazolidone on metronidazole-resistant Trichomonas vaginalis.
Narcisi EM; Secor WE
Antimicrob Agents Chemother; 1996 May; 40(5):1121-5. PubMed ID: 8723451
[TBL] [Abstract][Full Text] [Related]
8. Trichomonas vaginalis prevalence, incidence, risk factors and antibiotic-resistance in an adolescent population.
Krashin JW; Koumans EH; Bradshaw-Sydnor AC; Braxton JR; Evan Secor W; Sawyer MK; Markowitz LE
Sex Transm Dis; 2010 Jul; 37(7):440-4. PubMed ID: 20351623
[TBL] [Abstract][Full Text] [Related]
9. A systematic review of the literature on mechanisms of 5-nitroimidazole resistance in
Graves KJ; Novak J; Secor WE; Kissinger PJ; Schwebke JR; Muzny CA
Parasitology; 2020 Nov; 147(13):1383-1391. PubMed ID: 32729451
[TBL] [Abstract][Full Text] [Related]
10. Drug susceptibility testing in microaerophilic parasites: Cysteine strongly affects the effectivities of metronidazole and auranofin, a novel and promising antimicrobial.
Leitsch D
Int J Parasitol Drugs Drug Resist; 2017 Dec; 7(3):321-327. PubMed ID: 28910741
[TBL] [Abstract][Full Text] [Related]
11. Efficacy of new 5-nitroimidazoles against metronidazole-susceptible and -resistant Giardia, Trichomonas, and Entamoeba spp.
Upcroft JA; Campbell RW; Benakli K; Upcroft P; Vanelle P
Antimicrob Agents Chemother; 1999 Jan; 43(1):73-6. PubMed ID: 9869568
[TBL] [Abstract][Full Text] [Related]
12. The activity of protease inhibitors against Giardia duodenalis and metronidazole-resistant Trichomonas vaginalis.
Dunn LA; Andrews KT; McCarthy JS; Wright JM; Skinner-Adams TS; Upcroft P; Upcroft JA
Int J Antimicrob Agents; 2007 Jan; 29(1):98-102. PubMed ID: 17137752
[TBL] [Abstract][Full Text] [Related]
13. Drug library screening against metronidazole-sensitive and metronidazole-resistant Trichomonas vaginalis isolates.
Goodhew EB; Secor WE
Sex Transm Infect; 2013 Sep; 89(6):479-84. PubMed ID: 23794105
[TBL] [Abstract][Full Text] [Related]
14. Mycoplasma hominis infection of Trichomonas vaginalis is not associated with metronidazole-resistant trichomoniasis in clinical isolates from the United States.
Butler SE; Augostini P; Secor WE
Parasitol Res; 2010 Sep; 107(4):1023-7. PubMed ID: 20652315
[TBL] [Abstract][Full Text] [Related]
15. In vitro metronidazole and tinidazole activities against metronidazole-resistant strains of Trichomonas vaginalis.
Crowell AL; Sanders-Lewis KA; Secor WE
Antimicrob Agents Chemother; 2003 Apr; 47(4):1407-9. PubMed ID: 12654679
[TBL] [Abstract][Full Text] [Related]
16. Impaired parasite attachment as fitness cost of metronidazole resistance in Giardia lamblia.
Tejman-Yarden N; Millman M; Lauwaet T; Davids BJ; Gillin FD; Dunn L; Upcroft JA; Miyamoto Y; Eckmann L
Antimicrob Agents Chemother; 2011 Oct; 55(10):4643-51. PubMed ID: 21825286
[TBL] [Abstract][Full Text] [Related]
17. Tinidazole: a review of its antiprotozoal activity and therapeutic efficacy.
Sawyer PR; Brogden RN; Pinder RM; Speight TM; Avery GS
Drugs; 1976; 11(6):423-40. PubMed ID: 954609
[TBL] [Abstract][Full Text] [Related]
18. Strain of Trichomonas vaginalis resistant to metronidazole and other 5-nitroimidazoles.
Meingassner JG; Thurner J
Antimicrob Agents Chemother; 1979 Feb; 15(2):254-7. PubMed ID: 311617
[TBL] [Abstract][Full Text] [Related]
19. Discovery of novel antigiardiasis drug candidates.
Kulakova L; Galkin A; Chen CZ; Southall N; Marugan JJ; Zheng W; Herzberg O
Antimicrob Agents Chemother; 2014 Dec; 58(12):7303-11. PubMed ID: 25267663
[TBL] [Abstract][Full Text] [Related]
20. In Vitro Testing of Trichomonas vaginalis Drug Susceptibility: Evaluation of Minimal Lethal Concentrations for Metronidazole and Tinidazole That Correspond With Treatment Failure.
Augostini P; Bradley ELP; Raphael BH; Secor WE
Sex Transm Dis; 2023 Jun; 50(6):370-373. PubMed ID: 36849257
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
